Evangeline Lilly discusses her hospital visit after a beach accident caused by fainting, showing injuries and mentioning her childhood blackout episodes.

A clinical trial showed that Lilly's weight loss medicine is superior to a key competitor's product. Eli Lilly (NYSE: LLY) is one of the undisputed leaders in developing anti-obesity medicines ...

Eli Lilly's shares have been somewhat volatile this year, partly because of marketwide issues but also due to disappointing bottom-line guidance for the fiscal year 2025.

The creator of Sirens explained the abundance of Lilly Pulitzer dresses and what those lockets really mean.

Major pharmaceutical manufacturing company Eli Lilly is considering a $5.7 billion investment into a facility in Houston.

Investing.com -- Eli Lilly and Company (NYSE:LLY) is expanding its neuroscience pipeline through the acquisition of SiteOne Therapeutics in a deal worth up to $1 billion, deepening its bet on non ...

SiteOne Therapeutics is developing a non-opioid therapy that targets sodium ion channels in the human body to treat pain and sensory hyperexcitability disorders.

Evangeline Lilly is showing the extent of her facial injuries after fainting and hitting a boulder at the beach. “I fainted at the beach. And fell face-first into a boulder,” the Lost actress ...

Actress Evangeline Lilly shared photos of the gruesome injuries she sustained after fainting.

Eli Lilly is expanding its efforts to advance next-generation pain medications. The Big Pharma has penned a deal to acquire SiteOne Therapeutics, primarily for a non-opioid pain asset ready to ...

With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out potential sites for new drug ingredients plants. | Eli Lilly is jockeying for ...

Evangeline Lilly revealed that she recently fainted while at the beach, falling face first into a boulder. The actress said she believes that her passing out often is due to her body “checking ...